# Inflammatory Markers and Adverse Outcomes in Chronic Kidney Disease

> **NCT01974713** · — · COMPLETED · sponsor: **Institute of Kidney Lifescience Technologies** · enrollment: 2530 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01974713
- **Lead sponsor:** Institute of Kidney Lifescience Technologies
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2016-04
- **Final completion:** 2017-07
- **Target enrollment:** 2530 (ACTUAL)
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01974713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01974713, "Inflammatory Markers and Adverse Outcomes in Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01974713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*